BDNF Val66Met polymorphism and BDNF levels in obese pregnant women
DOI:
https://doi.org/10.18203/2320-6012.ijrms20264159Keywords:
Val66Met polymorphism, BDNF, Umbilical cord blood, Maternal obesity, Minangkabau ethnicityAbstract
Background: Maternal obesity is associated with chronic inflammation, oxidative stress, and metabolic alterations that may affect the intrauterine environment. Brain-derived neurotrophic factor (BDNF) plays an essential role in neuronal growth, neurogenesis, differentiation, and synaptic plasticity. The BDNF Val66Met (rs6265) polymorphism is a common genetic variant that may alter activity-dependent BDNF secretion. However, data regarding the distribution of this polymorphism and BDNF levels in obese pregnant women remain limited. The objective is to investigate the distribution of the BDNF Val66Met (rs6265) polymorphism and to determine maternal and umbilical cord blood BDNF levels among obese pregnant women.
Methods: This cross-sectional observational analytical study included 72 full-term obese pregnant women of Minangkabau ethnicity. The BDNF Val66Met polymorphism was analyzed using polymerase chain reaction (PCR), while BDNF concentrations in maternal and umbilical cord blood were measured using enzyme-linked immunosorbent assay (ELISA). Genotype distribution and BDNF concentrations were analyzed descriptively and statistically.
Results: The mutant BDNF Val66Met genotype was identified in 80.6% of the participants. The mean BDNF concentration in umbilical cord blood was 2.36 ng/ml, which was higher than the mean maternal BDNF concentration of 2.04 ng/ml. The findings demonstrated a high prevalence of the BDNF Val66Met mutant genotype and differences in BDNF concentrations between maternal and umbilical cord blood among obese pregnant women.
Conclusions: The BDNF Val66Met polymorphism was frequently observed among obese pregnant women. Umbilical cord blood BDNF concentrations were higher than maternal BDNF concentrations, indicating differences in maternal-fetal BDNF regulation in obese pregnancies. These findings provide insights into the genetic variation and BDNF profile associated with maternal obesity.
References
Aji AS, Lipoeto NI, Yusrawati Y, Malik SG, Kusmayanti NA, Susanto I, et al. Association between pre-pregnancy body mass index and gestational weight gain on pregnancy outcomes: a cohort study in Indonesian pregnant women. BMC Pregnancy Childbirth. 2022;22:492.
Khammarnia M, Ansari-Moghaddam A, Kakhki FG, Clark CCT, Barahouei FB. Maternal macronutrient and energy intake during pregnancy: a systematic review and meta-analysis. BMC Public Health. 2024;24:478.
Liu M, Shi Y, Shao C, Jia W, Li X, Tian J, et al. Analysis of obesity prevalence and trend prediction among professional women in a hospital from 2010 to 2024: a weight management perspective. BMC Public Health. 2025;25:4193.
Almutairi FS, Alsaykhan AM, Almatrood AA. Obesity prevalence and its impact on maternal and neonatal outcomes in pregnant women: a systematic review. Cureus. 2024;16(12).
Soltani H, Lipoeto NI, Fair FJ, Kilner K, Yusrawati Y. Pre-pregnancy body mass index and gestational weight gain and their effects on pregnancy and birth outcomes: a cohort study in West Sumatra, Indonesia. BMC Womens Health. 2017;17:102.
Yusrawati Y, Efrida E, Massi N, Fikri B, Shimojo N. Maternal vitamin D intake correlates with serum 25-hydroxyvitamin D, interleukin-6, and ferritin in maternal and umbilical cord. Sci Rep. 2025;15:32104.
Sulastri D, Lestari Y, Afriwardi, Desmawati. Relationship between body composition and smoking habit with telomere length of Minangkabau ethnicity men, in West Sumatera, Indonesia. Pak J Biol Sci. 2017;20(10):516-22. doi:10.3923/pjbs.2017.516.522.
Beneventi F, Bellingeri C, De Maggio I, Cavagnoli C, Fumanelli S, Ligari E, et al. Placental pathologic features in obesity. Placenta. 2023;144:1-7.
Zhang Z, He Z, Pan J, Yuan M, Lang Y, Wei X, et al. The interaction of BDNF with estrogen in the development of hypertension and obesity, particularly during menopause. Front Endocrinol (Lausanne). 2024;15:1384159.
Urbonaite G, Knyzeliene A, Bunn FS, Smalskys A, Neniskyte U. The impact of maternal high-fat diet on offspring neurodevelopment. Front Neurosci. 2022;16:909762.
Hidayat A, Arief M, Wijaya A, As’ad S. Vascular endothelial growth factor and brain-derived neurotropic factor levels in ischemic stroke subject. Indones Biomed J. 2016;8(2):115-8.
Chen NC, Chuang YC, Huang CW, Lui CC, Lee CC, Hsu SW, et al. Interictal serum brain-derived neurotrophic factor level reflects white matter integrity, epilepsy severity, and cognitive dysfunction in chronic temporal lobe epilepsy. Epilepsy Behav. 2016;59:147-54.
Ramos-Cejudo J, Gutiérrez-Fernández M, Otero-Ortega L, Rodríguez-Frutos B, Fuentes B, Vallejo-Cremades MT. Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke. Stroke. 2015;46(1):221-8.
Goldfield GS, Walsh J, Sigal RJ, Kenny GP, Hadjiyannakis S, De Lisio M, et al. Associations of the BDNF Val66Met polymorphism with body composition, cardiometabolic risk factors, and energy intake in youth with obesity: findings from the HEARTY study. Front Neurosci. 2021;15:715330.
Pérez-Gutiérrez AM, Rovira P, Gutiérrez B, Cervilla JA, Zarza-Rebollo JA, Molina E, et al. Influence of BDNF Val66Met genetic polymorphism in major depressive disorder and body mass index: evidence from a meta-analysis of 6481 individuals. J Affect Disord. 2024;344:458-65.
Xu MQ, St Clair D, Ott J, Feng GY, He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res. 2007;91(1-3):6-13.
Ng H, Alfian SD, Abdulah R, Barliana MI. BDNF Val66Met genotype is not associated with psychological distress: a cross-sectional study in Indonesian pharmacy young adults. Medicine (Baltimore). 2022;101(30).
Chouthai NS, Sampers J, Desai N, Smith GM. Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions. Pediatr Res. 2003;53(6):965-9.
Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z. Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring. Int J Mol Sci. 2021;22(6):2965.
Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Marchina E, Bellotti D, Milanesi E, et al. BDNF Val66Met polymorphism and protein levels in amniotic fluid. BMC Neurosci. 2010;11:16.
Peng JH, Liu CW, Pan SL, Wu HY, Liang QH, Gan RJ, et al. Potential unfavorable impacts of BDNF Val66Met polymorphisms on metabolic risks in average population in a longevous area. BMC Geriatr. 2017;17:4.
Granitzer S, Widhalm R, Atteneder S, Fernandez MF, Mustieles V, Zeisler H, et al. BDNF and KISS-1 levels in maternal serum, umbilical cord, and placenta: the potential role of maternal levels as effect biomarker. Expo Health. 2024;16:445-61.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aswin Boy Pratama, Yusrawati, Jamsari, Hardisman, Eny Yantri
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
